Related Experiment Videos
Microsphere-based duplexed immunoassay for influenza virus typing by flow cytometry.
Xiaomei Yan1, Erika G Schielke, Karen M Grace
1Bioscience Division, MS M888, Los Alamos National Laboratory, Los Alamos, NM 87545, USA. yan@lanl.gov
Journal of Immunological Methods
|January 23, 2004
Summary
This study introduces a rapid, sensitive microsphere immunoassay for distinguishing influenza A and B viruses. This advanced method offers improved detection over current kits and enhances global influenza surveillance capabilities.
Area of Science:
- Virology
- Immunology
- Biotechnology
Background:
- Current influenza virus detection methods have limitations in speed and sensitivity.
- Accurate and rapid characterization of influenza types is crucial for effective diagnosis and surveillance.
- Existing diagnostic kits often lack multiplexing capabilities and high sensitivity.
Purpose of the Study:
- To develop a rapid, duplexed microsphere-based immunoassay for characterizing influenza virus types A and B.
- To overcome limitations of current influenza detection methods.
- To enhance influenza surveillance through improved diagnostic capabilities.
Main Methods:
- Utilized microspheres of two sizes, each conjugated with specific monoclonal antibodies (MAbs) for influenza A or B capture.
- Employed fluorescently labeled polyclonal antibodies to detect captured viruses, forming sandwich complexes.
- Analyzed complexes using a multiparameter flow cytometer for simultaneous detection of influenza types.
Main Results:
- The assay successfully distinguished between influenza types A and B in a single reaction with high reproducibility and sensitivity.
- Achieved significantly higher detection sensitivity compared to commercially available rapid influenza diagnostic kits.
- Demonstrated multiplexing capabilities, reducing sample handling and reagent consumption compared to ELISA and other kits.
Conclusions:
- The developed microsphere immunoassay is an efficient and sensitive method for characterizing influenza types A and B.
- The assay's multiplexing potential allows for simultaneous differentiation of multiple influenza types and subtypes.
- This technology can be expanded for improved global influenza surveillance by incorporating subtype-specific antibodies.